LISA BRIONES: Open Payments
NPI 1477296960 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 27 payments from 8 companies in 2025. Trend: 2023 $173 · 2024 $354 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 10 | $286 |
| Madrigal Pharmaceuticals | 4 | $154 |
| Janssen Biotech, Inc. | 2 | $117 |
| ABBVIE INC. | 5 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| PFIZER INC. | 1 | $19 |
| Cranial Technologies, Inc | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: IQIRVO, REZDIFFRA, TREMFYA, CREON, XIFAXAN, LINZESS, VELSIPITY, Doc Band.
Industry payments across TX — which companies pay providers there.
